dipyridamole has been researched along with h 89 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Becker, GJ; Hewitson, TD; Kelynack, KJ; Martic, M; Tait, MG | 1 |
| Christie, MJ; Hack, SP; Vaughan, CW | 1 |
| Begandt, D; Bintig, W; Ngezahayo, A; Oberheide, K; Schlie, S | 1 |
| Fisher, MJ; Liu, S; Paganini-Hill, A; Yang, F; Yu, C | 1 |
| Chiba, S; Fujikura, Y; Ina, K; Tatsukawa, S; Wei, H; Yan, Q | 1 |
7 other study(ies) available for dipyridamole and h 89
| Article | Year |
|---|---|
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Dipyridamole inhibits in vitro renal fibroblast proliferation and collagen synthesis.
Topics: Animals; Cell Division; Cell Survival; Cells, Cultured; Collagen; Dipyridamole; Disease Models, Animal; Fibroblasts; Fluorescent Antibody Technique, Indirect; Immunoenzyme Techniques; In Situ Hybridization; Indoles; Isoquinolines; Kidney; Male; Maleimides; Nitric Oxide; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfonamides; Ureteral Obstruction | 2002 |
Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro.
Topics: Action Potentials; Adenosine; Affinity Labels; Animals; Colforsin; Cyclic AMP; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Enkephalins; Enzyme Inhibitors; gamma-Aminobutyric Acid; In Vitro Techniques; Isoquinolines; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Neural Inhibition; Neurons; Patch-Clamp Techniques; Periaqueductal Gray; Probenecid; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Substance Withdrawal Syndrome; Sulfonamides; Synaptic Transmission; Thioinosine; Time Factors; Uricosuric Agents; Vasodilator Agents; Xanthines | 2003 |
Dipyridamole increases gap junction coupling in bovine GM-7373 aortic endothelial cells by a cAMP-protein kinase A dependent pathway.
Topics: Animals; Cattle; Cell Line; Connexins; Cyclic AMP-Dependent Protein Kinases; Dipyridamole; Endothelial Cells; Fibrinolytic Agents; Gap Junctions; Isoquinolines; Models, Biological; Protein Kinase Inhibitors; Sulfonamides | 2010 |
Phosphodiesterase inhibitor modulation of brain microvascular endothelial cell barrier properties.
Topics: Actins; Brain; Capillary Permeability; Carbazoles; Cells, Cultured; Cilostazol; Claudin-5; Dipyridamole; Drug Interactions; Electric Impedance; Endothelial Cells; Histamine; Humans; Isoquinolines; Phosphodiesterase Inhibitors; Protein Kinase Inhibitors; Pyrroles; Rolipram; Sulfonamides; Tetrazoles | 2012 |
The signal pathway for the repressive effect of dipyridamole on myofibroblast transdifferentiation.
Topics: Actins; Animals; Benzene Derivatives; Biomarkers; Cell Line; Cell Transdifferentiation; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dipyridamole; Fibroblasts; Gene Expression Regulation; Guanine Nucleotide Exchange Factors; Isoquinolines; Kidney; Myofibroblasts; Phosphodiesterase Inhibitors; Protein Kinase Inhibitors; Rats; Signal Transduction; Sulfonamides; Sulfones; Transforming Growth Factor beta1 | 2019 |